These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


192 related items for PubMed ID: 10810746

  • 21. Investigation of the Effects of Excipients in the Compounding of Amlodipine Besylate Orally Disintegrating Tablets.
    Azmi NHS, Ming LC, Uddin ABMH, Sarker ZI, Bin LK.
    Int J Pharm Compd; 2022; 26(1):80-87. PubMed ID: 35081048
    [Abstract] [Full Text] [Related]

  • 22. A new apparatus for real-time assessment of the particle size distribution of disintegrating tablets.
    Quodbach J, Kleinebudde P.
    J Pharm Sci; 2014 Nov; 103(11):3657-3665. PubMed ID: 25223505
    [Abstract] [Full Text] [Related]

  • 23. The influence of granulation on super disintegrant performance.
    Zhao N, Augsburger LL.
    Pharm Dev Technol; 2006 Feb; 11(1):47-53. PubMed ID: 16544908
    [Abstract] [Full Text] [Related]

  • 24. Effect of Disintegrants on Prolongation of Tablet Disintegration Induced by Immersion in Xanthan Gum-Containing Thickening Solution: Contribution of Disintegrant Interactions with Disintegration Fluids.
    Sugiura D, Onuki Y, Fujita Y, Nakamura A, Harada T.
    Chem Pharm Bull (Tokyo); 2020 Feb; 68(11):1055-1060. PubMed ID: 33132372
    [Abstract] [Full Text] [Related]

  • 25. Improvement by super disintegrants of the properties of tablets containing lactose, prepared by wet granulation.
    van Kamp HV, Bolhuis GK, Lerk CF.
    Pharm Weekbl Sci; 1983 Aug 26; 5(4):165-71. PubMed ID: 6622211
    [Abstract] [Full Text] [Related]

  • 26. Assessment of disintegrant efficacy with fractal dimensions from real-time MRI.
    Quodbach J, Moussavi A, Tammer R, Frahm J, Kleinebudde P.
    Int J Pharm; 2014 Nov 20; 475(1-2):605-12. PubMed ID: 25234864
    [Abstract] [Full Text] [Related]

  • 27. Disintegrant Selection in Hydrophobic Tablet Formulations.
    Bauhuber S, Warnke G, Berardi A.
    J Pharm Sci; 2021 May 20; 110(5):2028-2037. PubMed ID: 33181185
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of fast disintegrants in terfenadine tablets containing a gas-evolving disintegrant.
    Sallam E, Ibrahim H, Dahab RA, Shubair M, Khalil E.
    Drug Dev Ind Pharm; 1998 Jun 20; 24(6):501-7. PubMed ID: 9876615
    [Abstract] [Full Text] [Related]

  • 29. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY, Lin KH, Li MJ.
    J Pharm Sci; 2002 Sep 20; 91(9):2040-6. PubMed ID: 12210050
    [Abstract] [Full Text] [Related]

  • 30. Development of fast disintegrating compressed tablets using amino acid as disintegration accelerator: evaluation of wetting and disintegration of tablet on the basis of surface free energy.
    Fukami J, Ozawa A, Yoshihashi Y, Yonemochi E, Terada K.
    Chem Pharm Bull (Tokyo); 2005 Dec 20; 53(12):1536-9. PubMed ID: 16327184
    [Abstract] [Full Text] [Related]

  • 31. Functionality comparison of 3 classes of superdisintegrants in promoting aspirin tablet disintegration and dissolution.
    Zhao N, Augsburger LL.
    AAPS PharmSciTech; 2005 Dec 12; 6(4):E634-40. PubMed ID: 16408865
    [Abstract] [Full Text] [Related]

  • 32. Disintegration of highly soluble immediate release tablets: a surrogate for dissolution.
    Gupta A, Hunt RL, Shah RB, Sayeed VA, Khan MA.
    AAPS PharmSciTech; 2009 Dec 12; 10(2):495-9. PubMed ID: 19387843
    [Abstract] [Full Text] [Related]

  • 33. Mimosa pudica seed mucilage: isolation; characterization and evaluation as tablet disintegrant and binder.
    Ahuja M, Kumar A, Yadav P, Singh K.
    Int J Biol Macromol; 2013 Jun 12; 57():105-10. PubMed ID: 23500434
    [Abstract] [Full Text] [Related]

  • 34. Chitin's Functionality as a Novel Disintegrant: Benchmarking Against Commonly Used Disintegrants in Different Physicochemical Environments.
    Chaheen M, Soulairol I, Bataille B, Yassine A, Belamie E, Sharkawi T.
    J Pharm Sci; 2017 Jul 12; 106(7):1839-1848. PubMed ID: 28392454
    [Abstract] [Full Text] [Related]

  • 35. Fast disintegrating tablets containing Rhodiola rosea L. extract.
    Kucinskaite A, Sawicki W, Briedis V, Sznitowska M.
    Acta Pol Pharm; 2007 Jul 12; 64(1):63-7. PubMed ID: 17665852
    [Abstract] [Full Text] [Related]

  • 36. Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets.
    Zaheer K, Langguth P.
    Drug Dev Ind Pharm; 2018 Mar 12; 44(3):444-451. PubMed ID: 29098885
    [Abstract] [Full Text] [Related]

  • 37. Investigation of Filler Effects on the Compounding of Freeze-dried Orodispersible Tablets Containing Annona muricata Extract.
    Azman SEN, Abd Razak FS, Kamal WHBW, Zheng GK, Ming LC, Uddin AH, Sarker ZI, Bin LK.
    Int J Pharm Compd; 2020 Mar 12; 24(6):509-514. PubMed ID: 33217741
    [Abstract] [Full Text] [Related]

  • 38. A critical review on tablet disintegration.
    Quodbach J, Kleinebudde P.
    Pharm Dev Technol; 2016 Sep 12; 21(6):763-74. PubMed ID: 25975586
    [Abstract] [Full Text] [Related]

  • 39. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
    Rasool BK, Fahmy SA, Galeel OW.
    Pak J Pharm Sci; 2012 Oct 12; 25(4):815-22. PubMed ID: 23009999
    [Abstract] [Full Text] [Related]

  • 40. Formulation and evaluation of nanocrystalline cellulose as a potential disintegrant.
    Wang C, Huang H, Jia M, Jin S, Zhao W, Cha R.
    Carbohydr Polym; 2015 Oct 05; 130():275-9. PubMed ID: 26076627
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.